Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.
Onchocerca volvulus is the nematode pathogen responsible for human onchocerciasis also known as "River blindness", a neglected tropical disease that affects up to 18 million people worldwide. Helminths Excretory Secretory Products (ESPs) constitute a rich repertoire of molecules that can b...
Saved in:
Main Authors: | Ferdinand Ngale Njume (Author), Stephen Mbigha Ghogomu (Author), Robert Adamu Shey (Author), Lea Olive Tchouate Gainkam (Author), Philippe Poelvoorde (Author), Perrine Humblet (Author), Joseph Kamgno (Author), Annie Robert (Author), Leon Mutesa (Author), Christophe Lelubre (Author), Evelina Edelweiss (Author), Arnaud Poterszman (Author), Susi Anheuser (Author), Luc Vanhamme (Author), Jacob Souopgui (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
by: Jessica A Hess, et al.
Published: (2016) -
Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017) -
Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
by: Parakkal Jovvian George, et al.
Published: (2019) -
The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
by: Fidelis Cho-Ngwa, et al.
Published: (2010) -
A Minniature ov Inglish Orthoggraphy
by: Elphinston, James, 1721-1809